parkinson’s

Jhillika Kumar is the Founder & CEO at Mentra, a neurodivergent-friendly talent platform that intelligently matches neurodiverse individuals with employers that value their strengths. Traditional talent and employment platforms tend to prioritize a certain kind of candidate, which can leave many highly-capable people without meaningful work. As our world changes, we have to realize that neurodivergence is not a weakness, but rather a strength for many mission critical roles. Mentra puts recruiters in front of candidates rather than forcing them to navigate through the challenging process of finding a job. How? Through humanistic AI and community-driven design. It’s an awesome concept whose time has most certainly come.

➡️ https://www.mentra.com/

➡️ Highlights: https://rosspalmer.com/jhillika-kumar

➡️ Follow me on Instagram: @therosspalmer

➡️ Subscribe on YouTube: @therosspalmer

0:39

A money and mental health talk with Shawnee Co. Commissioner Kevin Cook and why he says your voice matters in the budget process.

 

6:31 

The Topeka & Shawnee Co. Public Library rolls out the red carpet to celebrate 50 years of its Red Carpet Services Program.

 

11:12

Our guests race in with an invite to the Speedy PD Race for Parkinson’s Disease. It’s a benefit for the Parkinson’s programs at Manhattan’s Meadowlark Hills.

 

14:55 

Hello, Dolly! Dolly Parton visited Kansas to celebrate the statewide expansion of her Imagination Library program. Melissa recaps her exclusive one-on-one conversation with the icon and shares a bit of Dolly’s on-stage performance and comments.

When you trust in the Lord, there is always courage to go on.-------- Thank you for listening! Your support of Joni and Friends helps make this show possible.     Joni and Friends envisions a world where every person with a disability finds hope, dignity, and their place in the body of Christ. Become part of the global movement today at www.joniandfriends.org   Find more encouragement on Instagram, TikTok, Facebook, and YouTube.

We are in the midst of a Parkison’s pandemic—and yet, this pandemic is a relatively silent one. Parkinson’s is the world’s fastest growing neurological disorder, increasing in virtually every region in the world. In the U.S. alone, the economic cost of the diseases exceeds $50 billion a year—a staggering $50,000 per person with the disease. In today’s episode, we talk with Dr. Ray Dorsey, Professor of Neurology at the University of Rochester Medical Center and co-author of a thought-provoking new book, “Ending Parkinson’s Disease: A Prescription for Action.” As one of four leading physicians who co-author this book, Dr. Dorsey calls for a bold, comprehensive approach to help end Parkinson’s called PACT, which stands for Prevent. Advocate for, Care, and Treat the disease. He will talk about the most promising treatments on the horizon, from immune therapies to vaccines, surgical treatments, and new developments in nutrition and microbiome research. He’ll discuss the troubling use of pesticides and toxic chemicals linked to the disease, which particularly affect farmers, veterans, and high-tech manufacturing workers, as well as the rest of us. Dr. Dorsey will also outline some of the latest advances in care, including the dramatic increase in the use of telemedicine to treat Parkinson's patients. And he will examine the lessons learned from other health crises, from polio to AIDS and COVID-19—and how we might apply them to this pandemic. And finally, he will give us an action plan for what the average citizen can do right now to help end Parkinson’s. “Parkinson’s disease is not an inevitable disease that happens with age,” he notes. “It is a preventable disease, and we need to get around to preventing people from developing it in the first place.”

We are in the midst of a Parkison’s pandemic—and yet, this pandemic is a relatively silent one. Parkinson’s is the world’s fastest growing neurological disorder, increasing in virtually every region in the world. In the U.S. alone, the economic cost of the diseases exceeds $50 billion a year—a staggering $50,000 per person with the disease. In today’s episode, we talk with Dr. Ray Dorsey, Professor of Neurology at the University of Rochester Medical Center and co-author of a thought-provoking new book, “Ending Parkinson’s Disease: A Prescription for Action.” As one of four leading physicians who co-author this book, Dr. Dorsey calls for a bold, comprehensive approach to help end Parkinson’s called PACT, which stands for Prevent. Advocate for, Care, and Treat the disease. He will talk about the most promising treatments on the horizon, from immune therapies to vaccines, surgical treatments, and new developments in nutrition and microbiome research. He’ll discuss the troubling use of pesticides and toxic chemicals linked to the disease, which particularly affect farmers, veterans, and high-tech manufacturing workers, as well as the rest of us. Dr. Dorsey will also outline some of the latest advances in care, including the dramatic increase in the use of telemedicine to treat Parkinson's patients. And he will examine the lessons learned from other health crises, from polio to AIDS and COVID-19—and how we might apply them to this pandemic. And finally, he will give us an action plan for what the average citizen can do right now to help end Parkinson’s. “Parkinson’s disease is not an inevitable disease that happens with age,” he notes. “It is a preventable disease, and we need to get around to preventing people from developing it in the first place.”

Irene Litvan, MD, FAAN, FANA, Director of UC San Diego’s Movement Disorder Program, discusses the latest advances in detection and treatment of Parkinsonian Disorders including examples of her fascinating work in PSP and Parkinson’s disease. She will also provide practical advice for reducing the risk of developing these disorders. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 30569]

Irene Litvan, MD, FAAN, FANA, Director of UC San Diego’s Movement Disorder Program, discusses the latest advances in detection and treatment of Parkinsonian Disorders including examples of her fascinating work in PSP and Parkinson’s disease. She will also provide practical advice for reducing the risk of developing these disorders. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 30569]

While Parkinson’s disease is widely known as a motion disorder, it affects other areas of the brain including cognition. Bill Mobley welcomes Vincent Filoteo in a discussion of his efforts to understand these effects both as early signs of the disease and to devise treatments to ameliorate these cognitive effects. Series: "Brain Channel" [Health and Medicine] [Show ID: 30724]

While Parkinson’s disease is widely known as a motion disorder, it affects other areas of the brain including cognition. Bill Mobley welcomes Vincent Filoteo in a discussion of his efforts to understand these effects both as early signs of the disease and to devise treatments to ameliorate these cognitive effects. Series: "Brain Channel" [Health and Medicine] [Show ID: 30724]

Bill Mobley welcomes epidemiologist Harvey Checkoway in a fascinating discussion about exploring and revealing environmental factors contributing to Parkinson’s Disease and other motion disorders. Series: "Brain Channel" [Health and Medicine] [Show ID: 30530]

Bill Mobley welcomes epidemiologist Harvey Checkoway in a fascinating discussion about exploring and revealing environmental factors contributing to Parkinson’s Disease and other motion disorders. Series: "Brain Channel" [Health and Medicine] [Show ID: 30530]

Subtitled in Chinese: Parkinson’s disease is a degenerative neurological disease that manifests in many different ways often making it difficult to recognize. What new information do we have regarding the early symptoms of this disease, how it is diagnosed, and the latest treatment options? To help answer these questions, leading medical experts at UC San Francisco’s renowned Parkinson’s Disease Clinic and Research Center share their insights and expertise about the latest advances. People diagnosed with Parkinson’s also share their stories of what it is like to live with this unpredictable disease giving us a better window into Parkinson’s. [Health and Medicine] [Show ID: 29418]

Subtitled in Chinese: Parkinson’s disease is a degenerative neurological disease that manifests in many different ways often making it difficult to recognize. What new information do we have regarding the early symptoms of this disease, how it is diagnosed, and the latest treatment options? To help answer these questions, leading medical experts at UC San Francisco’s renowned Parkinson’s Disease Clinic and Research Center share their insights and expertise about the latest advances. People diagnosed with Parkinson’s also share their stories of what it is like to live with this unpredictable disease giving us a better window into Parkinson’s. [Health and Medicine] [Show ID: 29418]

Michael Okun, MD discusses the processes and prospects for deep brain stimulation (DBS). Learn why we apply electricity to the brain, how DBS works, and how we can use DBS to treat conditions such as Parkinson’s Disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 27925]

Michael Okun, MD discusses the processes and prospects for deep brain stimulation (DBS). Learn why we apply electricity to the brain, how DBS works, and how we can use DBS to treat conditions such as Parkinson’s Disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 27925]

What is it like to live with Parkinson’s, a degenerative neurological disease? Where do you turn for the latest treatment options delivered with compassionate care? To help answer these questions, people with Parkinson’s share their heartfelt stories of what it is like to live with this disease. Leading medical experts from UC San Francisco’s renowned Parkinson’s Disease Clinic and Research Center also share their expertise about the latest research. [Health and Medicine] [Show ID: 18008]

What is it like to live with Parkinson’s, a degenerative neurological disease? Where do you turn for the latest treatment options delivered with compassionate care? To help answer these questions, people with Parkinson’s share their heartfelt stories of what it is like to live with this disease. Leading medical experts from UC San Francisco’s renowned Parkinson’s Disease Clinic and Research Center also share their expertise about the latest research. [Health and Medicine] [Show ID: 18008]